These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date and reported results||2016-000460-42||A Phase 2, Randomized, Double-Blind, Placebo Controlled, Study to Evaluate Multiple Doses of AK001 in Patients With Moderate to Severe Nasal Polyposis||2018-01-05||bad-data|
|Ongoing||2017-002581-51||An Open-Label, Pilot Study to Assess the Efficacy and Safety Of AK002 (Siglec-8) in Patients with Antihistamine-Resistant Chronic Urticaria||not-yet-due|
|Exempt||2018-000165-36||A Phase 1b, Open-Label, Multiple-Dose, Proof-of-Concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AK002 in Patients with Peanut Allergy||not-yet-due|